ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC15093-25mg |
|
614726-85-1 |
AM4113
|
0 | C17H12Cl3N3O | |
GC15093-10mg |
|
614726-85-1 |
AM4113
|
0 | C17H12Cl3N3O | |
GC15093-5mg |
|
614726-85-1 |
AM4113
|
0 | C17H12Cl3N3O | |
GC15093-1mg |
|
614726-85-1 |
AM4113
|
0 | C17H12Cl3N3O | |
GC15092-50mg |
|
17375-63-2 |
BGC 20-761
|
0 | C19H22N2O | |
GC15092-10mg |
|
17375-63-2 |
BGC 20-761
|
0 | C19H22N2O | |
GC15091-10mg |
|
1094451-90-7 |
UCM05
|
0 | C24H16O10 | |
GC15091-5mg |
|
1094451-90-7 |
UCM05
|
0 | C24H16O10 | |
GC15091-1mg |
|
1094451-90-7 |
UCM05
|
0 | C24H16O10 | |
GC15090-10mM (in 1mL DMSO) |
|
376348-65-1 |
Maraviroc
|
0 | C29H41F2N5O | |
GC15090-25mg |
|
376348-65-1 |
Maraviroc
|
0 | C29H41F2N5O | |
GC15090-5mg |
|
376348-65-1 |
Maraviroc
|
0 | C29H41F2N5O | |
GC15089-10mM (in 1mL DMSO) |
|
868540-17-4 |
Carfilzomib (PR-171)
|
0 | C40H57N5O7 | |
GC15089-25mg |
|
868540-17-4 |
Carfilzomib (PR-171)
|
0 | C40H57N5O7 | |
GC15089-10mg |
|
868540-17-4 |
Carfilzomib (PR-171)
|
0 | C40H57N5O7 | |
GC15089-5mg |
|
868540-17-4 |
Carfilzomib (PR-171)
|
0 | C40H57N5O7 | |
GC15088-25mg |
|
1018899-04-1 |
LX-4211
|
0 | C21H25ClO5S | |
GC15088-5mg |
|
1018899-04-1 |
LX-4211
|
0 | C21H25ClO5S | |
GC15087-10mg |
|
57460-41-0 |
(±)-Talinolol
|
0 | C20H33N3O3 | |
GC15087-5mg |
|
57460-41-0 |
(±)-Talinolol
|
0 | C20H33N3O3 | |